IBS Signs up Aussie Pharma Firm

Sigma Co. looking for improvements in supply chain processes with industry-specific distribution solution

Stockholm — December 1, 2003 — Australian pharmaceuticals firm Sigma Co. Ltd. has signed an agreement with IBS in Australia for the installation of IBS' specialized software solution for pharmaceutical distribution, IBS Pharma. The agreement covers software, implementation, services and hardware in the amount of $5.4 million.

A 91-year-old company founded by two Melbourne pharmacists, Sigma today is a $1.2 billion manufacturer, wholesaler and retailer of pharmaceutical products headquartered in Clayton, Victoria.

The IBS solution that Sigma will deploy includes order management, customer service, distribution, warehouse management, logistics, supply chain management, financial control and management information. IBS' solution replaces Sigma's current legacy system.

"IBS' turnkey solution minimizes the project risk for us, and I look forward to the significant efficiency benefits and improved functionality that the new system will provide," said Elmo de Alwis, managing director of Sigma. "Our ability to better service our customers' requirements in a more complex environment will be enhanced by the successful implementation of the ASW system."

"The implementation of IBS Pharma, with its industry-specific functionality, is expected to facilitate further improvements in Sigma's supply chain processes and deliver significant business value," said Staffan Wensing, managing director of IBS Australia.

"This order shows the strength of our international focus on pharmaceutical distribution," said Magnus Wastenson, CEO of IBS.